PRYMF(PRYMF)
PRYMF
No analyst ratings available
No analyst price targets available for PRYMF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $21.89B | $23.67B | $25.38B | $26.63B | $27.70B |
| Low | $20.76B | $21.75B | $23.68B | $24.85B | $25.85B |
| High | $23.06B | $25.20B | $26.88B | $28.21B | $29.35B |
| EBITDA Avg | $1.98B | $2.14B | $2.30B | $2.41B | $2.51B |
| Low | $1.88B | $1.97B | $2.14B | $2.25B | $2.34B |
| High | $2.09B | $2.28B | $2.43B | $2.55B | $2.65B |
| EBIT Avg | $1.42B | $1.54B | $1.65B | $1.73B | $1.80B |
| Low | $1.35B | $1.41B | $1.54B | $1.61B | $1.68B |
| High | $1.50B | $1.64B | $1.75B | $1.83B | $1.91B |
| Net Income Avg | $1.42B | $1.78B | $2.09B | $2.68B | $3.04B |
| Low | $1.30B | $1.63B | $1.91B | $2.44B | $2.78B |
| High | $1.53B | $1.92B | $2.25B | $2.88B | $3.28B |
| EPS Avg | $4.82 | $6.03 | $7.07 | $9.07 | $10.30 |
| Low | $4.40 | $5.50 | $6.45 | $8.28 | $9.40 |
| High | $5.19 | $6.49 | $7.61 | $9.76 | $11.09 |
| Analysts (Rev / EPS) | 19 / 1 | 19 / 1 | 8 / 1 | 10 / 1 | 16 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $5.71B | $5.86B | $5.76B |
| Low | $5.61B | $5.76B | $5.67B |
| High | $5.84B | $5.99B | $5.89B |
| EBITDA Avg | $516M | $530M | $521M |
| Low | $508M | $521M | $513M |
| High | $528M | $542M | $533M |
| EBIT Avg | $371M | $380M | $374M |
| Low | $364M | $374M | $368M |
| High | $379M | $389M | $383M |
| Net Income Avg | $455M | $443M | $415M |
| Low | $445M | $434M | $406M |
| High | $469M | $456M | $427M |
| EPS Avg | $1.48 | $1.44 | $1.35 |
| Low | $1.45 | $1.41 | $1.32 |
| High | $1.52 | $1.48 | $1.39 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |